COVID-19

Pfizer and BioNTech have reported results from a phase 3 trial of their mRNA-based coronavirus vaccine candidate, BNT162b2. Read more about the efficacy here.

Moderna has announced that results of a phase 3 study show that the company’s mRNA-1273 vaccine is safe and effective.

Pfizer has released details from its first interim efficacy analysis of results from the current phase 3 trial of its COVID-19 vaccine candidate.

This COVID-19 roundup details the results of a recent study that examined how long antibodies remained detectable following disease onset, as well as a study which found that aspirin use could significantly...

The FDA has approved the first option for the treatment of adult and pediatric patients aged 12 years or older with COVID-19 who require hospitalization.

This roundup discusses recent findings detailing an immune system pathway that could help to inhibit the spread of COVID-19, as well as a new blood test and prognostic score that helps to predict disease...

The National Institutes of Health has released an update to its guidelines for COVID-19 treatment.

Holly Hendin, MD, PhD, spoke about the social, psychological, and physical impacts of the COVID-19 pandemic, as well as the impact the pandemic has had on health care providers and their patients.

This roundup discusses recent findings from a review conducted by CDC on cases of multisystem inflammatory syndrome in adult patients, as well as details on a new inexpensive, fast, paper COVID-19 test. ...